# Tris Pharma Inc. – FDA Inspection, Apr 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/868cb111-c9ed-4744-857d-5d267514ece7
Source feed: FDA_Inspections

> FDA inspection 1048300 of Tris Pharma Inc., April 16, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1048300
- Company Name: Tris Pharma Inc.
- Inspection Date: 2018-04-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1289086 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/b0a66ca1-e50e-48d8-8bb1-9e1b4802753b)
- [FDA Inspection 1232735 - 2024-03-08](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/99d56376-6034-4b6d-bb10-9c0588ba3b2d)
- [FDA Inspection 1143403 - 2021-06-08](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/0d3df2aa-17b0-4cd8-b8b1-3c73c074e44d)
- [FDA Inspection 1076980 - 2019-01-23](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/2d9231c8-f86c-4a28-96c0-54d7c9c16c2c)
- [FDA Inspection 1010216 - 2017-03-20](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/bbcf743c-d4e0-4c1b-9f1e-81f82bd0e447)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/tris-pharma-inc/65a6590a-3777-454b-bf0d-a9d37e3bf58e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c